Condition
Obstructive Sleep Apnea Syndrome
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
18 shownFactors Issued From Functional Exploration Associated to SAHOS in Asthmatic ChildrenNCT04624815 · 2020-11-20
TERMINATEDCombination Therapy Associating CPAP and Mandibular Advancement Device in OSANCT04021810 · 2019-11-18
TERMINATEDPeriodontitis as Signal for an Underlying DiseaseNCT03459638 · 2018-03-09
COMPLETEDSleep Apnea in Asthmatic Children and TeenagersNCT03034447 · 2016-12-01
COMPLETEDAspirin Resistance and Sleep Apnea in Type-2 Diabetic PatientsNCT01788930 · 2013-02-01
TERMINATEDEfficacy of CPAP Treatment on Blood Pressure of Resistant Hypertension Patients With Obstructive Sleep Apnea SyndromeNCT01508754 · 2012-01-01
COMPLETEDCPASMA: Is There an Improvement in Asthma in Patients With Both Asthma and OSAS Treated With CPAP?NCT01374932 · 2011-07-01
UNKNOWNPortable Monitoring Device for the Diagnosis of Sleep Apnea in Obese PatientsNCT01455077 · 2011-01-01
UNKNOWNThe Effect of Aerobic Interval Training on Obstructive Sleep ApneaNCT01215617 · 2010-10-01
COMPLETEDPerception of Pain During Obstructive Sleep Apnea Syndrome in Obese PatientNCT03277963 · 2010-02-04
COMPLETEDPortable Monitoring Device for the Diagnosis of Sleep Apnea in Patients With Chronic Obstructive Pulmonary DiseaseNCT01026207 · 2009-08-01
TERMINATEDRussian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in HypertensionNCT00801671 · 2008-09-01
COMPLETEDStudy of Ocular Blood Flow in Patients With Glaucoma and/or Obstructive Sleep Apnea Syndrome (OSAS)NCT00874913 · 2006-09-01
UNKNOWNLAGB as a Treatment for Morbid Obesity in AdolescentsNCT01045499 · 2005-09-13
COMPLETEDObstructive Sleep Apnea Syndrome in GlaucomaNCT00313092 · 2005-01-01
TERMINATEDInfluence of nCPAP on Metabolic Consequences Associated With OSASNCT00435643 · 2004-10-01
COMPLETEDPilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and AdolescentsNCT00222963 · 2004-09-01
COMPLETEDCardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea SyndromeNCT00764218 · 2001-03-01
UNKNOWNCommon interventions
CPAPDEVICE2Aerobic Interval trainingBEHAVIORAL1Continuous Positive Airway Pressure (CPAP) and patient educationDEVICE1Continuous positive airway pressure treatmentPROCEDURE1ControlBEHAVIORAL1cPAPPROCEDURE1Home Sleep StudyOTHER1Laparoscopic adjustable gastric banding (Allergan Lap Band)DEVICE1Lung Function TestOTHER1Mandibular Advancement DeviceDEVICE1measurement of ocular blood flowDEVICE1nasal continuous positive airway pressurePROCEDURE1nCPAP treatmentDEVICE1No positive airway pressure treatmentOTHER1Pain perception tests (mechanical : VON FREY ELECTRONIQUE or electrical stimulus : PAIN MATCHER®)DEVICE1PolysomnographyDEVICE1Positive airway pressure treatmentDEVICE1QuestionnaireOTHER1Screening for DM, ASCVD, MetS and OSASOTHER1
Leading sponsors
University Hospital, Grenoble4Federal University of São Paulo2Academic Centre for Dentistry in Amsterdam1Assistance Publique - Hôpitaux de Paris1Associação Fundo de Incentivo à Pesquisa1Associacao Fundo de Incentivo a Psicofarmcologia1Cimera1Jeffrey L Zitsman, MD1Norwegian University of Science and Technology1Russian Cardiology Research and Production Center1Selim Orguel1Universidade Federal do Rio de Janeiro1University Hospital, Clermont-Ferrand1University of Rochester1
Trial status mix
COMPLETED9
TERMINATED5
UNKNOWN4
Phase mix
NA8
PHASE32
EARLY_PHASE11
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.